全文获取类型
收费全文 | 2970篇 |
免费 | 330篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 116篇 |
妇产科学 | 34篇 |
基础医学 | 401篇 |
口腔科学 | 91篇 |
临床医学 | 339篇 |
内科学 | 605篇 |
皮肤病学 | 49篇 |
神经病学 | 295篇 |
特种医学 | 206篇 |
外科学 | 400篇 |
综合类 | 78篇 |
一般理论 | 11篇 |
预防医学 | 231篇 |
眼科学 | 104篇 |
药学 | 159篇 |
中国医学 | 5篇 |
肿瘤学 | 167篇 |
出版年
2021年 | 31篇 |
2020年 | 18篇 |
2019年 | 29篇 |
2018年 | 63篇 |
2017年 | 60篇 |
2016年 | 66篇 |
2015年 | 67篇 |
2014年 | 85篇 |
2013年 | 122篇 |
2012年 | 134篇 |
2011年 | 124篇 |
2010年 | 104篇 |
2009年 | 99篇 |
2008年 | 117篇 |
2007年 | 122篇 |
2006年 | 116篇 |
2005年 | 96篇 |
2004年 | 101篇 |
2003年 | 112篇 |
2002年 | 107篇 |
2001年 | 92篇 |
2000年 | 94篇 |
1999年 | 81篇 |
1998年 | 97篇 |
1997年 | 76篇 |
1996年 | 79篇 |
1995年 | 63篇 |
1994年 | 53篇 |
1993年 | 60篇 |
1992年 | 65篇 |
1991年 | 56篇 |
1990年 | 52篇 |
1989年 | 49篇 |
1988年 | 53篇 |
1987年 | 54篇 |
1986年 | 43篇 |
1985年 | 43篇 |
1984年 | 31篇 |
1983年 | 35篇 |
1982年 | 20篇 |
1981年 | 28篇 |
1980年 | 24篇 |
1979年 | 33篇 |
1978年 | 29篇 |
1977年 | 27篇 |
1976年 | 17篇 |
1975年 | 20篇 |
1974年 | 22篇 |
1973年 | 22篇 |
1971年 | 14篇 |
排序方式: 共有3315条查询结果,搜索用时 15 毫秒
1.
2.
3.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
4.
5.
L. Rosenberg M.D. I. T. Jackson D. Sharpe J. Weiss 《European journal of plastic surgery》1987,9(4):158-159
Summary A system which can be used for injection or infiltration of large volumes of fluid is described. This consists of a syringe which fills automatically from a reservoir through an inlet/outlet valve. 相似文献
6.
In a prospective, randomized, double-blind study, 49 patients underwent lumbar myelography using iotrol (24 patients) or metrizamide (25 patients). The diagnostic imaging adequacy of iotrol was comparable with that of metrizamide. After iotrol myelography, adverse reactions were fewer, less severe, and of shorter duration than were those following metrizamide myelography. Thirteen of 24 patients (54%) receiving iotrol reported some adverse reactions compared with 24 of 25 patients (96%) receiving metrizamide. Five moderate and one severe adverse reaction occurred in the group receiving iotrol. Fourteen moderate and eight severe adverse reactions occurred in the group receiving metrizamide. Thirty-eight patients underwent electroencephalography both before and after myelography (19 iotrol and 19 metrizamide). None of the EEGs obtained after iotrol myelography changed from baseline, while seven of the EEGs obtained after metrizamide myelography showed changes from baseline. Iotrol was judged superior to metrizamide as a contrast medium in this patient population. 相似文献
7.
8.
Results of previous studies have shown that when rats consume higher concentrations of ethanol during initiation both the amount consumed and the pattern of consumption change with the return to a lower concentration. In this study, an across-sessions breakpoint procedure in the sipper-tube model was used to examine the effect that experience with drinking higher concentrations (a concentration manipulation) of both ethanol and sucrose had on appetitive and consummatory behaviors. A follow-up study was then conducted in the ethanol-consuming group with across-session breakpoint and intake examined before, during, and after a 3% sucrose/10% ethanol solution was presented in the sipper tube. As ethanol concentration increased, intake was not changed. Exposure to higher ethanol concentrations had no effect on the amount of 10% ethanol consumed when retested. The exposure tended to increase appetitive behavior (breakpoint), but this effect was not unique to ethanol, as rats self-administering 3% sucrose showed a similar increase. When the combined ethanol-sucrose solution was available, a significant increase in both intake and appetitive responding occurred; however, there was no change from prior intake or breakpoint when 10% ethanol was retested. That the addition of sucrose to the ethanol solution significantly increased appetitive and consummatory behaviors supports the suggestion that the composition of the alcoholic beverage can have a strong influence over the control of self-administration. Because most consumption of ethanol by human beings is in solutions that contain mixers that alter the taste of the solution, this taste factor needs to be considered in the regulation of ethanol drinking. 相似文献
9.
Lionel Sharpe 《Drug and alcohol review》1987,6(Z1):11-14
Abstract: Twenty-six part-time students from a variety of professional backgrounds are enrolled in the first year of a Graduate Diploma in Social Science (Drug Dependence) at the Phillip Institute of Technology in Victoria. The course is conducted under the auspices of the School of Social Work and commenced in 1984. It is argued that the graduates from this unique course could play a key role in providing personnel to fill positions in the areas of clinical work, staff development, drug education, programme development and management and research. 相似文献
10.